How ADAR1 can drive Disease Progression by Acting Both as an RNA Editor of Specific Transcripts & as a DNA Mutator of their Cognate Genes

Time: 1:00 pm
day: Day Two

Details:

• Evaluating RNA editing vs DNA mutation in cancer
• (Some) deaminases can act as RNA editors and DNA mutators
• Exploiting dual function enzymes for therapeutic purposes

Speakers: